Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P
Ali, Fares E M
Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P [electronic resource] - Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association Oct 2018 - 294-304 p. digital
Publication Type: Journal Article
1873-6351
10.1016/j.fct.2018.07.027 doi
Animals
Cholestasis--drug therapy
Diosmin--pharmacology
Drug Therapy, Combination
Kelch-Like ECH-Associated Protein 1--metabolism
Liver--drug effects
Liver Cirrhosis--drug therapy
Male
NF-E2-Related Factor 2--metabolism
NF-kappa B--metabolism
Nitric Oxide Synthase Type II--metabolism
Rats, Wistar
Signal Transduction
Sildenafil Citrate--pharmacology
p38 Mitogen-Activated Protein Kinases--metabolism
Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P [electronic resource] - Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association Oct 2018 - 294-304 p. digital
Publication Type: Journal Article
1873-6351
10.1016/j.fct.2018.07.027 doi
Animals
Cholestasis--drug therapy
Diosmin--pharmacology
Drug Therapy, Combination
Kelch-Like ECH-Associated Protein 1--metabolism
Liver--drug effects
Liver Cirrhosis--drug therapy
Male
NF-E2-Related Factor 2--metabolism
NF-kappa B--metabolism
Nitric Oxide Synthase Type II--metabolism
Rats, Wistar
Signal Transduction
Sildenafil Citrate--pharmacology
p38 Mitogen-Activated Protein Kinases--metabolism